US Lawmaker Seeks Answers on FDA Inspection of Musk's Neuralink

Tuesday, 26 March 2024, 10:24
A U.S. lawmaker raises concerns about the FDA's oversight of Elon Musk's Neuralink, questioning why the brain implant company was not inspected before conducting human tests. The FDA's decision-making process is under scrutiny for potential gaps in safety protocols and regulatory compliance.
https://store.livarava.com/fd859065-eb5b-11ee-aebc-63fd8ea994ba.jpg
US Lawmaker Seeks Answers on FDA Inspection of Musk's Neuralink

US Lawmaker Questions FDA Inspection of Musk's Neuralink

By Marisa Taylor

A U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk's Neuralink before allowing the brain implant company to test its device in humans.

Reuters

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe